|
HS Code |
918726 |
| Productname | 2-Amino-5-Bromonicaraldehyde |
| Molecularformula | C6H5BrN2O2 |
| Molecularweight | 217.02 g/mol |
| Casnumber | 184001-02-7 |
| Appearance | Light yellow to brown crystalline powder |
| Purity | Typically ≥98% |
| Meltingpoint | 172-176°C |
| Solubility | Slightly soluble in water; soluble in organic solvents |
| Storageconditions | Store at 2-8°C, protected from light and moisture |
| Smiles | C1=CC(=C(N=C1C=O)N)Br |
| Synonyms | 2-Amino-5-bromo-1,3-benzenedicarboxaldehyde |
As an accredited 2-Amino-5-Bromonicaraldehyde factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-Amino-5-Bromonicaraldehyde prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Sitting at the intersection of chemistry’s precision and practical problem-solving, 2-Amino-5-Bromonicaraldehyde stands out for researchers and professionals who need stability and reliability in their synthetic pathways. This molecule doesn’t attract attention because of a catchy name or glamorous branding, but rather for quietly solving real problems in pharmaceuticals, agrochemicals, and fine chemistry. You might wonder why a single compound generates interest in laboratories and production settings. There’s no magic here—just sound structure and solid performance.
2-Amino-5-Bromonicaraldehyde isn’t just another building block tucked away on a chemical shelf. The character of this compound comes from its molecular arrangement: an amino group snug at the second carbon, a bromo at the fifth, and twin aldehyde groups lending reactive versatility. That mix of electron-rich and electron-deficient centers opens up avenues for complex, highly targeted transformations. While many intermediates stall or trigger side reactions under intense conditions, this product withstands the test, letting scientists push through arduous routes without losing product integrity.
In pharmaceutical development, the demands on intermediates reach beyond the ordinary. Researchers look for more than theoretical yield figures and catalog promises; they want consistency during scale-up and purity that meets tight regulatory requirements. My experience in grad school taught me that hunting for analogs or derivatives with active groups in just the right position can easily drain time and budget. The unique setup of the bromo and amino functionalities in this compound means you don’t run into the delays or losses that often crop up with less thoughtfully designed intermediates.
Every chemist knows the pain of chasing down contamination and variability from batch to batch. With 2-Amino-5-Bromonicaraldehyde, quality doesn’t come as an afterthought. High purity levels—consistently tested by validated analytical methods—mean you can focus on what matters: creating value, solving problems, hitting those yield targets. Specifications typically include tight controls on moisture and trace impurity profiles, addressing practical hurdles like reactivity or solvent compatibility in demanding syntheses.
Melting point and solubility data come straight from the bench, not just the book. This kind of transparency adds confidence when you’re scaling up or passing product between teams. Small changes in melting range can spell trouble in later steps or during final isolation, but the stability of this compound helps sidestep those late-stage surprises. I’ve seen teams forced into unplanned process changes because of small but significant drifts in intermediate profiles—2-Amino-5-Bromonicaraldehyde offers a cleaner slate.
In many discovery and manufacturing settings, the journey from molecule to medicine travels through a chain of tightly controlled chemical events. 2-Amino-5-Bromonicaraldehyde fits into this chain with a role that’s both flexible and crucial. The aldehyde groups provide access to important ring closure reactions, allowing rapid construction of heterocycles found in many modern drugs. Combining this bromo group with the amino functionality lets you carry out cross-coupling, nucleophilic substitution, or reductive amination with fewer competing side products. That reduces time spent on purification and boosts the likelihood that something useful will come out of each reaction cycle.
Pharmaceutical innovators look for molecules that enable a diversity of transformations. This product brings that, with reactivity that covers Suzuki, Buchwald, and other palladium-catalyzed couplings. In my own work synthesizing kinase inhibitors, switching out less well-defined intermediates for this one meant less troubleshooting and more reliable GO/NO-GO decisions. Far from being a one-trick reagent, 2-Amino-5-Bromonicaraldehyde adapts to the task at hand, whether it’s forming a critical amide bond or serving as a scaffold in combinatorial chemistry.
Agrochemical routes demand production at scale without running afoul of environmental or safety constraints. The stability and selectivity of this compound mean process teams can optimize around greener solvents and milder temperatures, directly addressing regulatory and sustainability pressure. You don’t need high-pressure hydrogenation setups or harsh mineral acids to drive most key steps with this intermediate. The result is both smaller waste streams and improved worker safety. During a stint at a contract research organization, I watched as a client’s preclinical candidate made a smoother transition to pilot-scale because the intermediate didn’t require extra purging or laborious clean-up just to meet downstream purity targets.
Plenty of intermediates crowd the market. It’s easy to thumb through supplier lists and spot ten substitutes sporting similar-sounding names. Yet working chemists quickly learn that not all “close alternatives” live up to the job once you get past theory and into practice. Analogues with only the amino or bromo group often come with mismatched reactivity or extra steps to introduce the missing scaffold—leading to longer timelines and higher cost of goods.
Some products with similar ring systems break down during key functionalization stages or form intractable mixtures under standard coupling conditions. Others arrive with unpredictable impurity profiles, especially if suppliers take shortcuts in synthesis or crystallization. 2-Amino-5-Bromonicaraldehyde instead brings a rigorously tested approach; you’re not trading off impurity headaches for slightly easier access up front. The dual presence of amino and bromine groups allows for cross-coupling or nucleophilic substitution in sequences routinely used by both small biotech outfits and major pharmaceutical players alike.
That practical difference isn’t just academic—it ripples through the entire development process. As someone who’s spent time scaling up multi-step routes, cutting extraneous purification or workup steps saves more than just time—it means less solvent use, smaller reactor footprints, and a more predictable path to regulatory submissions. Many alternatives require extra chelating agents or scavenger resins to handle metal residues post-coupling, bumping up process cost and validation time. This product’s performance lets project teams focus research dollars where they make the biggest impact.
Reliable sources document the use of 2-Amino-5-Bromonicaraldehyde as a core intermediate in the preparation of fused bicyclic heterocycles, with several peer-reviewed articles referencing its role in efficient library synthesis. Researchers at academic and industrial labs report consistent reactivity profiles, low byproduct formation, and strong batch reproducibility. Analytical results often show single-digit ppm levels for major trace impurities, exceeding many globally recognized regulatory baselines.
Beyond bench chemistry, large-scale use highlights its compatibility with established process safety guidelines. Documented thermal gravimetric analysis and differential scanning calorimetry data indicate solid thermal stability, broadening the range of operational conditions for both kilo-lab and plant-scale work. With such published evidence, product selection can move forward on clear footing, whether you’re constructing a new combinatorial library or optimizing en route to a clinical trial batch.
Solubility in common organic solvents like DMF, DMSO, and acetonitrile accelerates integration into high-throughput screening or scale-up purification regimes. A lack of excessive volatility or hydrolytic sensitivity also means less monitoring for product loss or degradation over time. For users facing tough deadlines or rushed projects, those practical attributes make all the difference.
Real-world R&D doesn’t stand still. There’s always new pressure from regulators, patients, and internal review boards to deliver better outcomes, faster. 2-Amino-5-Bromonicaraldehyde becomes an answer not just because of what it is, but because of what it lets researchers accomplish. Simplifying synthetic routes opens up capacity on crowded project timelines. Cutting batch-to-batch variability enables a smoother climb from preclinical experiments to production campaigns. Stability reduces the need to overcompensate with harsh conditions, letting teams design processes safer for both operators and the environment.
Looking ahead, sustainability carries more weight than ever. Environmental metrics factor into procurement just as much as reactivity or cost. This product’s reliable performance in milder reaction conditions helps companies move away from toxic solvents or high-energy processes. That translates to real, measurable impact, both in regulatory filings and in the bottom line.
You also can’t ignore the value it brings to collaborations. Outsourcing and partnerships increasingly define modern drug and chemical discovery, with project teams spanning multiple time zones and expertise levels. Being able to specify an intermediate with proven handling characteristics and documented regulatory history makes tech transfer less risky and more productive. Instead of guessing how a batch might behave in a new plant, process chemists work from a shared foundation. In my experience, intermediates with a track record for stable handling become the “go-to” solutions that provide reliable anchors for many pipeline projects.
In the day-to-day push of synthetic chemistry, time and resources rarely stretch as far as project leaders would like. I’ve watched junior scientists wrestle with alternatives that promise cost savings on paper but add hassle and variability in practice. Each shortcut brings its own challenges—instability, contamination by unexpected byproducts, or the need for tricky purification steps. 2-Amino-5-Bromonicaraldehyde helps sidestep these issues. Its twin functional groups mean more direct access to the desired transformation, often eliminating intermediate protection/deprotection tricks that eat up days in the lab.
For high-throughput chemistry, clean reactivity and manageable solubility help compound libraries move from design to bench to screening with less manual handling. Automation systems handle this molecule without clogging or degradation, streamlining workflows in both research and process development groups. You win efficiency gains not just in chemistry, but in the team’s overall momentum.
From my own work in synthetic labs and project management, the products you end up relying on aren’t always the ones with the slickest brochures. Instead, it’s the intermediates that earn trust with every use—the ones that don’t surprise you with failed couplings or mysterious new spots on a chromatogram after scale-up. 2-Amino-5-Bromonicaraldehyde’s predictable behavior makes a strong case for inclusion in both hit-finding and process optimization environments.
Controlling risks means having fewer unknowns at every development stage. This avoids the fire drills and late-night rescue plans often triggered by unstable or ill-defined intermediates. Stability grants chemists the confidence to make bolder choices downstream, exploring new chemical space or pushing more ambitious scale without constantly reassessing intermediate integrity.
No one can afford to overlook regulatory scrutiny in the age of global supply chains and closely watched drug launches. Documented analytical trails and robust impurity management reduce the chance of project slowdowns due to compliance questions. Reproducible spectra and chain-of-custody validation bring peace of mind, especially when tech transfer stretches across continents or partners.
Shorter process times and cleaner step transitions feed directly into cost containment and regulatory compliance. You don’t need to allocate extra cycles for re-validation because batches behave as predicted. The result is fewer disruptions in manufacturing campaigns and a faster path to market for new therapies or specialty products.
It’s easy for products to become pigeonholed as “just another fine chemical intermediate.” But the role of 2-Amino-5-Bromonicaraldehyde extends across boundaries—fueling innovation not just in drugs, but in advanced materials and specialty compounds. In coordination and organometallic chemistry, its scaffold provides access to novel ligand systems that shape new catalysts or functional materials.
With many industries moving towards complex molecular targets, these versatile intermediates bridge the gap between research ambitions and real-world solutions. As a result, teams gain the flexibility to chase big ideas—while sticking with a reliable, proven tool that keeps projects on track.
Every lab and production plant feels the pressure to convert investment and effort into tangible progress. 2-Amino-5-Bromonicaraldehyde may not carry the flash of new-to-the-world discoveries, but its performance brings quiet certainty to even the most challenging synthetic campaigns. Its thoughtful balance of reactivity, stability, and purity addresses both the technical and operational hurdles that can turn a promising project into a process headache.
Time after time, intermediates like this—backed by published data and solid field experience—create the space and confidence needed for researchers, process chemists, and manufacturers to deliver on demanding schedules. Choosing tools that work the first time is more than a matter of convenience; it’s a way to ensure your team spends more time solving big problems, and less time wrestling with the basics. That’s a win worth repeating in any sector that needs science to deliver both innovation and reliability.